论文部分内容阅读
在美国和欧洲,再生障碍性贫血(再障)为一罕见病,以往报道再障年发病率为2～6/百万,最近根据人群研究提示,上述范围的低值更正确。1980年至1986年间,在欧洲和以色列进行了粒细胞减少症和再障国际综合性研究。结果表明各地间年发病率在0.6～3.0/百万之间,平均为2/百万。英国和法国的前瞻性研究结果与此接近,分别为2.3/百万和1.4/百万。相反,在东方国家再障则较常见。日本全
In the United States and Europe, aplastic anemia (aplastic anemia) is a rare disease, reported in the past the annual incidence of aplastic anemia is 2 ~ 6 / million, according to recent population studies suggest that the low value of the above range is more correct. Between 1980 and 1986, an international comprehensive study of neutrophils and aplasia was conducted in Europe and Israel. The results showed that the annual incidence of between 0.6 to 3.0 / million, with an average of 2 / million. Prospective findings from the UK and France are close to this, at 2.3 per million and 1.4 per million respectively. In contrast, aplasia in the East is more common. Japan all